Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

Eleftherios Mylonakis, Joseph Lutaakome, Mamta K. Jain, Angela J. Rogers, José Moltó, Susana Benet, Ahmad Mourad, D. Clark Files, Henry Mugerwa, Cissy Kityo, Francis Kiweewa, Mary Grace Nalubega, Jonathan Kitonsa, Evelyn Nabenkema, Daniel D. Murray, Dominique Braun, Dena Kamel, Elizabeth S. Higgs, Timothy J. Hatlen, Virginia L. KanAdriana Sanchez, John Tierney, Eileen Denner, Deborah Wentworth, Abdel G. Babiker, Victoria J. Davey, Annetine C. Gelijns, Gail V. Matthews, B. Taylor Thompson, H. Clifford Lane, James D. Neaton, Jens D. Lundgren

Research output: Contribution to journalComment/debatepeer-review

Abstract

The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.

Original languageEnglish (US)
Pages (from-to)531-537
Number of pages7
JournalMed
Volume3
Issue number8
DOIs
StatePublished - Aug 12 2022
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)'. Together they form a unique fingerprint.

Cite this